Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Syndax Pharmaceuticals Inc Common stock, par value $0.0001 per share (SNDX).
- Disclosed ownership: 5%.
- Date of event: 21 Jan 2025.
Point72 Asset Management, L.P. - 21 Jan 2025 SCHEDULE 13G Report for Syndax Pharmaceuticals Inc Common stock, par value $0.0001 per share (SNDX)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- SNDX
- Shares outstanding
- 85,556,940 shares
- Disclosed Ownership
- 4,277,847 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 22 Jan 2025, 17:50:55 UTC
- Date of event
- 21 Jan 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 5% ownership in Syndax Pharmaceuticals Inc Common stock, par value $0.0001 per share (SNDX) on 21 Jan 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 22 Jan 2025, 17:50.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 5% | 4,277,847 | 0 | 4,277,847 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 5% | 4,277,847 | 0 | 4,277,847 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 5% | 4,277,847 | 0 | 4,277,847 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |